BioMarin Pharmaceutical | BMRN - Market Capitalization


BioMarin Pharmaceutical reported $11.41B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.28B 480M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 204.97B 15.08B Aug/2026
Bayer EUR 47.7B 9.01B Aug/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.41B 550M Aug/2026
Gilead Sciences USD 162.48B 10.51B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
Insmed USD 35.3B 1.82B Mar/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 113.52B 3.82B Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 0 Aug/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026